NGEN
NervGen Pharma Corp.
NASDAQ: NGEN · HEALTHCARE · BIOTECHNOLOGY
$3.63
-3.20% today
Updated 2026-04-30
Market cap
$311.58M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$2 – $6
Volume
0.2M
NervGen Pharma Corp. (NGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,458.00%
ROA
-73.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-15.29M | — | — | — |
| 2023 | $0.00 | $-16.89M | — | — | — |
| 2024 | $0.00 | $-16.68M | — | — | — |
| 2025 | $0.00 | $-44.12M | — | — | — |